5-(2,5-Dichlorothiophen-3-yl)-1-(4-methoxyphenyl)-1H-pyrazole

Catalog No. :
ACWMIL330
CAS No. :
318256-33-6
Molecular Formula :
C14H10Cl2N2OS
Molecular Weight :
325.22

IUPAC Name:5-(2,5-dichlorothiophen-3-yl)-1-(4-methoxyphenyl)-1H-pyrazole

5-(2,5-Dichlorothiophen-3-yl)-1-(4-methoxyphenyl)-1H-pyrazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(2,5-Dichlorothiophen-3-yl)-1-(4-methoxyphenyl)-1H-pyrazole
IUPAC Name5-(2,5-dichlorothiophen-3-yl)-1-(4-methoxyphenyl)-1H-pyrazole
MDL No.MFCD01316682
Molecular FormulaC14H10Cl2N2OS
Molecular Weight325.22
SMILESCOC1=CC=C(N2N=CC=C2C3=C(Cl)SC(Cl)=C3)C=C1
InChI KeyAJMQYOIFCCXFMW-UHFFFAOYSA-N
Synonym4-[5-(2,5-DICHLORO-3-THIENYL)-1H-PYRAZOL-1-YL]PHENYL METHYL ETHER;5-(2,5-DICHLORO-3-THIENYL)-1-(4-METHOXYPHENYL)-1H-PYRAZOLE;5-(2,5-dichlorothiophen-3-yl)-1-(4-methoxyphenyl)-1H-pyrazole;1H-Pyrazole, 5-(2,5-dichloro-3-thienyl)-1-(4-methoxyphenyl)-
CAS No.318256-33-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACWMIL330 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSIGC147 route compound structure diagram
    ACSIGC14720265-97-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWMIL330 route product structure diagram
    ACWMIL330318256-33-6
Inquiry

2. ACWMIL330 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGURQ736 route compound structure diagram
    ACGURQ73619501-58-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWMIL330 route product structure diagram
    ACWMIL330318256-33-6
Inquiry

Comments (0)